CELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion 03/15/2021 Company news Read press release
04/14/2021 | 3d bioprinting CELLINK receives the prestigious gold award for the BIO X6 and wins two design excellence awards for the C.WASH and UP.SIGHT at the iF Design Awards 2021
04/14/2021 | Industry News CELLINK and UPM Biomedicals has formed a collaboration for ground-breaking 3D bioprinting developments
03/23/2021 | 3d bioprinting BIO X6 wins prestigious Red Dot Design Award for outstanding design quality
03/15/2021 | 3d bioprinting CELLINK launches the BIO MDX Series, a scaled-up revolution in biomedical manufacturing
03/15/2021 | Company news CELLINK AB announces the completion of the offering of Senior Unsecured Convertible Bonds convertible into Class B shares and a Class B share issue in an overall amount of SEK 3.0 billion
03/15/2021 | Company news CELLINK has entered into an agreement to acquire MatTek, the global leader in in-vitro technology and alternative drug testing models